Cardinal Health (CAH) Stock Forecast & Price Target $137.20 -0.57 (-0.41%) Closing price 04/1/2025 03:59 PM EasternExtended Trading$137.14 -0.07 (-0.05%) As of 04/1/2025 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cardinal Health - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Consensus Rating Moderate BuyBased on 14 Analyst RatingsSell0Hold4Buy10 Based on 14 Wall Street analysts who have issued ratings for Cardinal Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 4 have given a hold rating, and 10 have given a buy rating for CAH. Consensus Price Target $140.142.14% Upside According to the 14 analysts' twelve-month price targets for Cardinal Health, the average price target is $140.14. The highest price target for CAH is $150.00, while the lowest price target for CAH is $124.00. The average price target represents a forecasted upside of 2.14% from the current price of $137.20. Get the Latest News and Ratings for CAH and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cardinal Health and its competitors. Enter your email to sign up for newsletter Sign Up CAH Analyst Ratings Over TimeTypeCurrent Forecast4/2/24 to 4/2/251 Month Ago3/3/24 to 3/3/253 Months Ago1/3/24 to 1/2/251 Year Ago4/3/23 to 4/2/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy10 Buy rating(s)10 Buy rating(s)8 Buy rating(s)7 Buy rating(s)Hold4 Hold rating(s)4 Hold rating(s)5 Hold rating(s)3 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)1 Sell rating(s)Consensus Price Target$140.14$139.36$127.50$103.07Forecasted Upside2.14% Upside8.06% Upside8.03% Upside-7.32% DownsideConsensus RatingModerate BuyModerate BuyModerate BuyModerate Buy Remove Ads CAH Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History CAH Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Cardinal Health Stock vs. The CompetitionTypeCardinal HealthMedical CompaniesS&P 500Consensus Rating Score 2.71 2.82 2.54Consensus RatingModerate BuyModerate BuyModerate BuyPredicted Upside2.14% Upside19,837.88% Upside19.03% UpsideNews Sentiment RatingPositive NewsSee Recent CAH NewsPositive NewsPositive News Remove Ads Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails3/31/2025Mizuho3 of 5 starsS. ValiquetteSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetOutperform ➝ Outperform$142.00 ➝ $150.00+9.95%2/5/2025Jefferies Financial Group2 of 5 starsBrian TanquilutSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$140.00 ➝ $150.00+19.72%2/4/2025Argus2 of 5 starsKristina RuggeriSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Target$148.00+16.57%2/4/2025JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLisa GillSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetNeutral ➝ Neutral$142.00 ➝ $145.00+13.97%2/4/2025Wells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingS. BaxterSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetEqual Weight ➝ Equal Weight$135.00 ➝ $136.00+7.36%1/31/2025Morgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingErin WrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetOverweight ➝ Overweight$136.00 ➝ $142.00+10.67%1/10/2025CitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingDaniel GrosslightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetNeutral ➝ Neutral$120.00 ➝ $129.00+5.25%1/8/2025TD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingC. RhyeeSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$130.00 ➝ $144.00+18.90%1/7/2025Evercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingE. AndersonSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeIn-Line ➝ Outperform$140.00 ➝ $140.00+17.17%1/6/2025Bank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating UpgradeNeutral ➝ Buy$132.00 ➝ $145.00+21.54% Get the Latest News and Ratings for CAH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter. 11/4/2024Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetHold ➝ Hold$119.00 ➝ $124.00+9.48%11/4/2024UBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetBuy ➝ Buy$134.00 ➝ $139.00+21.30%11/4/2024BarclaysSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetOverweight ➝ Overweight$117.00 ➝ $133.00+14.53%8/15/2024Robert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetOutperform ➝ Outperform$130.00 ➝ $137.00+28.81%2/26/2024Leerink PartnrsSubscribe to MarketBeat All Access for the recommendation accuracy ratingM. ChernySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform2/26/2024Leerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageOutperform$125.00+15.64%6/12/2023Credit Suisse GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost Target$90.00 ➝ $100.00+15.82%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 03:38 AM ET. Should I Buy Cardinal Health Stock? CAH Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, March 30, 2025. Please send any questions or comments about these Cardinal Health pros and cons to contact@marketbeat.com. Cardinal Health Bull Case Here are some ways that investors could benefit from investing in Cardinal Health, Inc.: The stock is currently priced at $136.43, reflecting a strong performance and potential for growth, especially given its recent upgrades from multiple analysts. Cardinal Health, Inc. has received a consensus rating of "Moderate Buy" from analysts, indicating positive sentiment and confidence in the company's future performance. The company recently reported earnings per share (EPS) of $1.93, surpassing the consensus estimate of $1.74, which demonstrates strong financial performance and operational efficiency. Cardinal Health, Inc. has a market capitalization of $32.96 billion, suggesting it is a significant player in the healthcare sector, which can provide stability and growth opportunities for investors. The firm has announced a quarterly dividend of $0.5056 per share, translating to an annualized dividend yield of 1.48%, which can provide a steady income stream for investors. Cardinal Health Bear Case Investors should be bearish about investing in Cardinal Health, Inc. for these reasons: The company has a negative return on equity of 59.57%, indicating that it is not generating profit effectively from its equity, which could raise concerns about management efficiency. Cardinal Health, Inc. has a relatively low net margin of 0.59%, suggesting that the company may face challenges in converting revenue into actual profit, which could impact long-term growth. Despite recent upgrades, four analysts have rated the stock with a hold rating, indicating some uncertainty about its future performance compared to other investment opportunities. The stock has a price-to-earnings (P/E) ratio of 25.45, which may be considered high compared to industry averages, potentially indicating that the stock is overvalued. Market volatility, as indicated by a beta of 0.66, suggests that while the stock may be less volatile than the market, it still carries risks that could affect its performance in uncertain economic conditions. CAH Forecast - Frequently Asked Questions What is Cardinal Health's forecast for 2025? According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Cardinal Health is $140.14, with a high forecast of $150.00 and a low forecast of $124.00. Should I buy or sell Cardinal Health stock right now? 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last twelve months. There are currently 4 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CAH shares. Does Cardinal Health's stock price have much upside? According to analysts, Cardinal Health's stock has a predicted upside of 2.14% based on their 12-month stock forecasts. Has Cardinal Health been upgraded by Wall Street analysts recently? Over the previous 90 days, Cardinal Health's stock had 4 upgrades by analysts. What analysts cover Cardinal Health? Cardinal Health has been rated by research analysts at Argus, Bank of America, Citigroup, Evercore ISI, Jefferies Financial Group, JPMorgan Chase & Co., Mizuho, Morgan Stanley, TD Cowen, and Wells Fargo & Company in the past 90 days. Do Wall Street analysts like Cardinal Health more than its competitors? Analysts like Cardinal Health less than other "medical" companies. The consensus rating score for Cardinal Health is 2.71 while the average consensus rating score for "medical" companies is 2.82. Learn more on how CAH compares to other companies. Stock Forecasts and Research Tools Related Companies McKesson Stock Forecast Cencora Stock Forecast Henry Schein Stock Forecast Patterson Companies Stock Forecast Owens & Minor Stock Forecast Herbalife Stock Forecast Nu Skin Enterprises Stock Forecast Vertex Pharmaceuticals Stock Forecast Bristol-Myers Squibb Stock Forecast Medtronic Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NYSE:CAH) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Tax Shock?Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardinal Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardinal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
